The Application of Positive End-Expiratory Pressure in Out-of-Hospital Cardiac Arrest: The Lazarus-PEEP Trial.
Condition(s) studied
Investigational drug(s) / intervention(s)
Disposable PEEP Valve set at 5 cm H20.: Ventilation during cardiac arrest with an adult Resuscitation Bag with a pressure relief valve set at 40 cm H20 and a 22 mm disposable PEEP Valve set at 5 cm H20.
Controle: Ventilation during cardiac arrest with an adult Resuscitation Bag with a pressure relief valve set at 40 cm H20 without a disposable PEEP Valve.
Study summary
The goal of this clinical trial is to learn whether using Positive End-Expiratory Pressure (PEEP) during cardiopulmonary resuscitation (CPR) improves outcomes for adults who experience out-of-hospital cardiac arrest, a condition where the heart suddenly stops beating. PEEP is used during ventilation, which may enhance oxygen levels by keeping the airways open throughout CPR.
This study aims to determine if using PEEP during CPR helps restart the heart more effectively, improves survival rates, and enhances survival with good neurologic outcomes after a cardiac arrest compared to standard CPR without PEEP.
Researchers will randomly assign participants to one of two groups: one receiving CPR with PEEP set at 5 cm of water pressure and the other receiving standard CPR without PEEP. Participants will be treated by emergency medical teams trained in advanced life support, and specialised sensors will measure airflow and airway pressure during resuscitation.
Additionally, the study will evaluate potential side effects associated with PEEP, such as increased pressure within the chest or lung injuries. Findings from this trial will guide recommendations on the usage of PEEP in standard CPR practices to potentially improve patient outcomes.
Eligibility
Primary outcome measure(s)
- Return of spontaneous circulation (ROSC) — Day one
The occurrence of Return of spontaneous circulation (ROSC), defined as the return of sustained spontaneous circulation for at least 20 minutes per ERC guidelines
Trial sites (7)
| Facility | City | Region | Status |
|---|---|---|---|
| AZ Oostende | Ostend | West-Flandres | Recruiting |
| AZORG: campus Merestraat | Aalst | Belgium | Recruiting |
| AZORG: Campus Moorselbaan | Aalst | Belgium | Recruiting |
| AZORG: campus Geraardsbergen | Geraardsbergen | Belgium | Recruiting |
| UZ Ghent | Ghent | Belgium | Recruiting |
| AZ Zeno | Knokke | Belgium | Recruiting |
| Centre hospitalier universitaire (CHU) Besançon-Franche-Comté | Besançon | France | Active Not Recruiting |
More University Hospital, Ghent trials in Belgium
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06939335 on ClinicalTrials.gov ↗ ← All trials in Belgium